General Safety and Tolerability of Subcutaneous Tanezumab for Osteoarthritis: A Pooled Analysis of Three Randomized, Placebo‐Controlled Trials - Sorbonne Université
Journal Articles Arthritis Care & Research = Arthritis Care and Research Year : 2022

General Safety and Tolerability of Subcutaneous Tanezumab for Osteoarthritis: A Pooled Analysis of Three Randomized, Placebo‐Controlled Trials

Francis Berenbaum
Centre de Recherche Saint-Antoine
Thomas Schnitzer
  • Function : Author
Alan Kivitz
  • Function : Author
Lars Viktrup
  • Function : Author
Anne Hickman
  • Function : Author
Glenn Pixton
  • Function : Author
Mark Brown
  • Function : Author
Isabelle Davignon
  • Function : Author
Christine West
  • Function : Author

Domains

Life Sciences [q-bio]

francis berenbaum  : Connect in order to contact the contributor

https://hal.sorbonne-universite.fr/hal-03994756

Submitted on : Friday, February 17, 2023-4:21:30 PM

Last modification on : Thursday, December 14, 2023-1:50:38 PM

No file

Dates and versions

hal-03994756 , version 1 (17-02-2023)

Identifiers

Cite

Francis Berenbaum, Thomas Schnitzer, Alan Kivitz, Lars Viktrup, Anne Hickman, et al.. General Safety and Tolerability of Subcutaneous Tanezumab for Osteoarthritis: A Pooled Analysis of Three Randomized, Placebo‐Controlled Trials. Arthritis Care & Research = Arthritis Care and Research, 2022, 74 (6), pp.918-928. ⟨10.1002/acr.24637⟩. ⟨hal-03994756⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

U938 SORBONNE-UNIVERSITE SU-MEDECINE
3 View
0 Download

Altmetric

Share

More